Carbonara, Italy

Massimo Pregnolato

This inventor holds 1 USPTO granted patent. Top assignee: Adorken Technology Spa. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Massimo Pregnolato. Retrieved from https://idiyas.com/inventor/massimo-pregnolato

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Discovering the Innovations of Massimo Pregnolato

Introduction

Massimo Pregnolato, a prominent inventor residing in Carbonara al Ticino, Italy, has made significant contributions to the pharmaceutical field. With a keen focus on drug synthesis, his work is revolutionizing the way certain medications are prepared and processed.

Latest Patents

Massimo holds a patent for a remarkable innovation titled "Chemo-enzymatic process for the preparation of escitalopram." This patent details a process for synthesizing escitalopram and its pharmaceutically acceptable salts. Specifically, it involves obtaining an intermediate from 4-(4-dimethylamino)-1-(4'-fluorophenyl)-1-(hydroxybutyl)-3-(acyloxymethyl)benzonitrile. The innovative aspect of this process is the enzymatic enantiomeric resolution that converts the intermediate into the (S+) enantiomer of citalopram, providing an important step for efficient drug development.

Career Highlights

Massimo Pregnolato is associated with Adorken Technology Spa, a company known for its advancements in technology and pharmaceuticals. His work there has been pivotal, allowing him to apply his expertise in practical and impactful ways. Massimo's innovative approach contributes to the ongoing advancements in the pharmaceutical industry, particularly in the realm of antidepressants.

Collaborations

Throughout his career, Massimo has collaborated with talented coworkers, including Giovanni Cotticelli and Silvia Rocchietti. These partnerships have fostered an environment of creativity and innovation, enabling the team to share knowledge and effectively tackle complex challenges in drug synthesis.

Conclusion

Massimo Pregnolato's innovative contributions through his patents highlight the importance of creativity and scientific inquiry in the pharmaceutical industry. His work not only emphasizes the significance of collaboration but also showcases how dedicated inventors can have a profound impact on healthcare solutions. With a promising career marked by unique inventions, Massimo continues to be a beacon of innovation in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…